Cuprina Holdings
Singapore-based MedTech company that specialises in the development of products to treat chronic wounds. MEDIFLY, a bio-dressing made of live, medical-grade maggots, is used by private and public hospitals in Singapore and Hong Kong to disinfect and debride chronic wounds, known as Maggot Debridement Therapy (MDT). Our product is clinically-proven to reduce amputation rates and eliminate infections in chronic wounds, especially diabetic foot ulcers and pressure ulcers. We are ISO13485 certified and our MEDIFLY products are HSA registered as class C medical devices.
Cuprina develops bio-dressing using ‘maggot debridement therapy'
The biotech’s product, MEDIFLY, is an innovative approach to help eliminate necrotic tissues in wounds.
Cuprina develops bio-dressing using ‘maggot debridement therapy'
The biotech’s product, MEDIFLY, is an innovative approach to help eliminate necrotic tissues in wounds.
Resource Center
Awards
Apr
10
Events
Apr
09
Event News
Event News
Highlight your innovative medical initiatives at Healthcare Asia Awards, Medtech Awards, Pharma Awards 2025
Co-Written / Partner
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
Co-Written / Partner
Highlight your innovative medical initiatives at Healthcare Asia Awards, Medtech Awards, Pharma Awards 2025
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
Videos
Partner Sites
Join the community
Awards
Apr
10
Events
Apr
09